Intertek Expands GLP Bioanalytical Centre of Excellence In San Diego, California
10/21/2015
According to company officials, its expansion in capacity and new technology of the San Diego facility, which spans 46,000 square feet of laboratories, offices and sample storage, will benefit customers involved in preclinical and clinical development of small molecule drugs and biologic medicines. Investment in new bioanalytical technologies further strengthens capabilities to expedite delivery of fast and cost-effective bioanalysis results for global clients.
Mark Hammond, Intertek Pharmaceutical Services Business Leader said, “Our expanded GLP Bioanalytical Centre of Excellence in San Diego and new technologies provide a broader range of bioanalytical, biomarker, and cell-based capabilities services to meet our clients’ needs in preclinical and clinical bioanalysis, helping them to understand the safety, efficacy and mechanism of action of their small and large molecule drugs in development.”
Chetan Parmar, Senior Vice President of Intertek Life Sciences, said, “With recent expansion in bioanalytical capabilities in both the US and Europe, we further strengthen our capability to address the challenges our clients encounter during drug development through delivery of excellent global bioanalytical services."
The facility offers new technologies such as flow cytometry which will provide clients with robust and comprehensive analysis of cells to help understand the mechanism of action of drugs and facilitate evaluation of drug stability and potency. Furthermore, flow cytometry opens up an additional platform for assessing cell based neutralizing antibody activity in clinical trials, which is important in assessing any potential adverse immunological effects.
Luminex, another new technology at this site, will build on current high throughput and multiplexing capabilities to allow customised measurement of up to 100 analytes simultaneously using very small volumes of sample, officials said. This is ideal for studies where there is limited sample volume. Additional investment in new state-of-the-art liquid chromatography- mass spectrometry instruments not only upgrade Intertek's small molecule bioanalysis capabilities but also improve sensitivity and mass range for analysis of protein therapeutics.
Project Announcements
Zekelman Industries Expands Blytheville, Arkansas, Operations
04/19/2024
Fibrebond Corporation Expands Webster Parish, Louisiana, Operations
04/19/2024
Master Steel Expands Hardeeville, South Carolina, Operations
04/19/2024
L3Harris Technologies Expands Orange County, Virginia, Operations
04/18/2024
Republic Airways Holdings Plans Tuskegee, Alabama, Training Operations
04/18/2024
South Africa-Based Radel Plans Winston-Salem, North Carolina, Operations
04/18/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
Manufacturing Momentum Is Building
Q1 2024
-
Making Hybrid More Human in 2024
Q1 2024
-
20th Annual Consultants Survey: Clients Prioritize Access to Skilled Labor, Responsive State & Local Government
Q1 2024
-
Public-Private Partnerships Incentivize Industrial Development
Q1 2024